티아(옥사)졸로피리딘 화합물 및 이의 제조 방법
    1.
    发明公开
    티아(옥사)졸로피리딘 화합물 및 이의 제조 방법 失效
    THIA(OXA)ZOLOPYRIDINE化合物及其制备方法

    公开(公告)号:KR1020100035063A

    公开(公告)日:2010-04-02

    申请号:KR1020080094366

    申请日:2008-09-25

    CPC classification number: C07D513/04 C07D498/04

    Abstract: PURPOSE: A thia(oxa)zolopyridine compound and a method for preparing the same are provided to suppress beta-amyloid fibril formation and use as an agent for preventing and treating neurodegenerative diseases. CONSTITUTION: A thia(oxa)zolopyridine compound is denoted by chemical formula 1. The compound of chemical formula 1 is prepared by cyclizing a compound of chemical formula 2. An agent for suppressing formation of beta-amyloid fibril contains the thia(oxa)zolopyridine compound of chemical formula 1 or pharmaceutically acceptable salt as an active ingredient. A pharmaceutical composition for treating neurodegenerative diseases contains the thia(oxa)zolopyridine compound or pharmaceutically acceptable salt as an active ingredient.

    Abstract translation: 目的:提供硫代(oxa)唑吡啶化合物及其制备方法以抑制β-淀粉样蛋白原纤维形成和用作预防和治疗神经变性疾病的药剂。 构成:化学式1表示噻吩(oxa)唑吡啶化合物。化学式1的化合物是通过使化学式2的化合物环化而制备的。用于抑制β-淀粉样蛋白原纤维形成的试剂含有硫代(oxa)唑吡啶 化学式1的化合物或其药学上可接受的盐作为活性成分。 用于治疗神经变性疾病的药物组合物含有硫代(oxa)唑吡啶化合物或其药学上可接受的盐作为活性成分。

Patent Agency Ranking